Anticonvulsant effect of enhancement of noradrenergic transmission in the superior colliculus in genetically epilepsy-prone rats (GEPRs): A microinjection study

Brain Research

Volumn 780, Issue 2, 1998, Pages 199-209

  Yan, Qing Shan ^a   Dailey, John W ^a   Steenbergen, Jennifer L ^a   Jobe, Phillip C ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

Author keywords

1 agonist; 1 antagonist; 2 antagonist; Genetically epilepsy prone rat; Noradrenergic transmission; Norepinephrine uptake blocker; Superior colliculus

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; DESIPRAMINE; IDAZOXAN; METHOXAMINE; NISOXETINE; PHENYLEPHRINE; PRAZOSIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; AUDIOGENIC SEIZURE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DISEASE PREDISPOSITION; DISEASE SEVERITY; DOSE RESPONSE; EPILEPSY; FEMALE; MICROINJECTION; NERVE ENDING; NEUROTRANSMISSION; NONHUMAN; NORADRENERGIC SYSTEM; PRIORITY JOURNAL; RAT; SUPERIOR COLLICULUS;

ADRENERGIC ALPHA-AGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ADRENERGIC UPTAKE INHIBITORS; ANIMALS; ANTICONVULSANTS; DESIPRAMINE; DRUG INTERACTIONS; EPILEPSY; FEMALE; FLUOXETINE; IDAZOXAN; METHOXAMINE; MICROINJECTIONS; NOREPINEPHRINE; PHENYLEPHRINE; PRAZOSIN; RATS; RATS, INBRED STRAINS; SUPERIOR COLLICULUS; SYNAPTIC TRANSMISSION;

EID: 0032509761     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(97)01139-6     Document Type: Article

References (38)

1. Browning R.A., Wang C., Lanker M.L., Jobe P.C. Electroshock- and pentylenetetrazol-induced seizures in genetically epilepsy-prone rats (GEPRs): Differences in threshold and pattern. Epilepsy Res. 6:1990;1-11.
2. Carter A.J. Hippocampal noradrenaline release in awake, freely moving rats is regulated by alpha-2 adrenoceptors but not by adenosine receptors. J. Pharmacol. Exp. Ther. 281:1997;648-654.
3. Dailey J.W., Jobe P.C. Anticonvulsant drugs and the genetically epilepsy-prone rat. Fed. Proc. 44:1985;2640-2644.
4. Dailey J.W., Reigel C.E., Mishra P.K., Jobe P.C. Neurobiology of seizure predisposition in the genetically epilepsy-prone rat. Epilepsy Res. 3:1989;3-17.
5. Dailey J.W., Mishra P.K., Ko K.H., Penny J.E., Jobe P.C. Noradrenergic abnormalities in the central nervous system of seizure-naïve genetically epilepsy-prone rats. Epilepsia. 32:1991;168-173.
6. Dailey J.W., Mishra P.K., Ko K.H., Penny J.E., Jobe P.C. Serotonergic abnormalities in the central nervous system of seizure-naïve genetically epilepsy-prone rats. Life Sci. 50:1992;319-326.
7. Dean P., Gale K. Anticonvulsant action of GABA receptor blockade in the nigrotectal target region. Brain Res. 477:1989;391-395.
8. Dennis T., L'Heureux R., carter C., Scatton B. Presynaptic alpha-2 adrenoceptors play a major role in the effects of idazoxan on cortical noradrenaline release (as measured by in vivo dialysis) in the rat. J. Pharmacol. Exp. Ther. 241:1987;642-649.
9. DiChiara G., Poreddu M.L., Morelli M., Mulas M.L., Gessa G.L. Evidence for a GABAergic projection from the substantia nigra to the ventromedial thalamus and to the superior colliculus of the rat. Brain Res. 176:1979;272-284.
10. th ed., McGraw-Hill, New York, 1996, pp. 216.
11. th ed., McGraw-Hill, New York, 1996, pp. 431-459.
12. th ed., McGraw-Hill, New York, 1996, pp. 229-230.
13. Jobe P.C., Picchioni A.L., Chin L. Role of brain norepinephrine on audiogenic seizure in the rat. J. Pharmacol. Exp. Ther. 184:1973;1-10.
14. Jobe P.C., Burger R.L., Dailey J.W., Wang C., Browning R.A., Mishra P.K. Is the noradrenergic site of brainstem seizure regulation located within midbrain? Studies with desipramine infused via microdialysis in the GEPR. Epilepsia. 33:1992;35.
15. P.C. Jobe, P.K. Mishira, J.W. Dailey, Genetically epilepsy-prone rats: Actions of antiepileptic drugs and monoaminergic neurotransmitters, in: C.L. Faingold, G.H. Fromm (Eds.), Drugs for Control of Epilepsy: Actions on Neuronal Networks Involved in Seizure Disorders, CRC Press, Boca Raton, FL, 1992, pp. 253-275.
16. P.C. Jobe, P.K. Mishira, N. Ludvig, J.W. Dailey, Genetic models of the epilepsies, in: P.A. Schwartzkroin (Ed.), Epilepsy: Models, Mechanisms, and Concepts, Cambridge University Press, Cambridge, 1993, pp. 94-140.
17. P.C. Jobe, P.K. Mishra, N. Ludvig, J.W. Dailey, Recent advances in genetic models of the epilepsies, in: P.A. Schwartzkroin (Ed.), Epilepsy: Models, Mechanisms, and Concepts, Cambridge University Press, Cambridge, 1993, pp. 494-499.
18. Jobe P.C., Mishra P.K., Browning R.A., Wang C., Adam-Curtis L.E., Ko K.H., Dailey J.W. Noradrenergic abnormalities in the genetically epilepsy-prone rat. Brain Res. Bull. 35:1994;493-504.
19. Lasley S.M. Roles of neurotransmitter amino acids in seizure severity and experience in the genetically epilepsy-prone rat. Brain Res. 560:1991;63-70.
20. Lasley S.M., Yan Q.S. Diminished potassium-stimulated GABA release in vivo in genetically epilepsy-prone rats. Neurosci. Lett. 175:1994;145-148.
21. Meyerhoff J.L., Carter R.E., Yourick D.L., Slusher B.S., Coyle J.T. Genetically epilepsy-prone rats have increased brain regional activity of an enzyme which liberates glutamate from N-acetyl-aspartyl-glutamate. Brain Res. 593:1992;140-143.
22. Millan M.H., Meldrum B.S., Boersma C.A., Faingold C.L. Excitant amino acids and audiogenic seizures in the genetically epilepsy-prone rat. II. Efferent seizure propagating pathway. Exp. Neurol. 99:1988;687-698.
23. Mishra P.K., Dailey J.W., Reigel C.E., Tomsic M.L., Jobe P.C. Sex-specific distinctions in audiogenic convulsions exhibited by severe seizure genetically epilepsy-prone rats (GEPRs). Epilepsy Res. 2:1988;309-316.
24. G. Paxinos, C. Watson, The Rat Brain in Stereotaxic Coordinates, 2nd ed., Academic Press, New York, 1986.
25. Reigel C.E., Dailey J.W., Jobe P.C. The genetically epilepsy-prone rat: An overview of seizure-prone characteristics and responsiveness to anticonvulsant drugs. Life Sci. 39:1986;763-774.
26. Reigel C.E., Jobe P.C., Dailey J.W., Stewart J.J. Responsiveness of genetically epilepsy-prone rats to intracerebroventricular morphine-induced convulsions. Life Sci. 42:1988;1743-1749.
27. Ribak C.E., Manio A.L., Navetta M.S., Gall C.M. In situ hybridization for c-fos mRNA reveals the involvement of the superior colliculus in the propagation of seizure activity in genetically epilepsy-prone rats. Epilepsy Res. 26:1997;397-406.
28. Richelson E., Pfeenning M. Blockade by antidepressants and related compounds of biogenic amines uptake into rat brain synaptosomes: most antidepressants selectively block norepinephrine uptake. Eur. J. Pharmacol. 104:1984;277-286.
29. Savage D.D., Reigel C.E., Jobe P.C. Angular bundle kindling is accelerated in rats with a genetic predisposition to acoustic stimulus-induced seizures. Brain Res. 376:1986;412-415.
30. Shehab S., Simkins M., Dean P., Redgrave P. The dorsal midbrain anticonvulsant zone. I. Effects of locally administered excitatory amino acids or bicuculline on maximal electroshock seizure. Neuroscience. 65:1995;671-679.
31. Thomas D.N., Holman R.B. A microdialysis study of the regulation of endogenous noradrenaline release in the rat hippocampus. J. Neurochem. 56:1991;1741-1746.
32. Vincent S.R., Hattori T., McGeer E.G. The nigrotectal projection: a biochemical and ultrastructural characterization. Brain Res. 1551:1978;159-164.
33. Walter D.S., Flockhart I.R., Haynes M.J., Howlett D.R. Effects of idazoxan on catecholamine systems in rat brain. Biochem. Pharmacol. 33:1984;2553-2557.
34. Yan Q.S., Jobe P.C., Dailey J.W. Thalamic deficiency in norepinephrine release detected via intracerebral microdialysis: A synaptic determinant of seizure predisposition in the genetically epilepsy-prone rat. Epilepsy Res. 14:1993;229-236.
35. Yan Q.S., Jobe P.C., Dailey J.W. Noradrenergic mechanisms for the anticonvulsant effects of desipramine and yohimbine in genetically epilepsy-prone rats: studies with microdialysis. Brain Res. 610:1993;24-31.
36. Yan Q.S., Jobe P.C., Dailey J.W. Evidence that serotonergic mechanism is involved in the anticonvulsant effect of fluoxetine in genetically epilepsy-prone rats. Eur. J. Pharmacol. 252:1994;105-112.
37. Yan Q.S., Jobe P.C., Dailey J.W. Further evidence of anticonvulsant role for 5-hydroxytryptamine in genetically epilepsy-prone rats. Br. J. Pharmacol. 115:1995;1314-1318.
38. Yan Q.S., Dickerson J., Jobe P.C., Dailey J.W. Anticonvulsant effect of enhancement of noradrenergic transmission in the superior colliculus in genetically epilepsy-prone rats. (GEPRs): a microinjection study. Soc. Neurosci. Abstr. 21:1996;1966.